The beta-thalassaemias are a heterogeneous group of inherited disorder
s caused by mutations in and around the structural gene of the beta-ch
ain of the adult haemoglobin (HbA). Studies at the gene level have ide
ntified a large number of beta-thalassaemia gene variations in differe
nt populations. These findings have implications for the use of molecu
lar diagnosis for genetic counselling and prenatal detection of the be
ta-thalassaemias. In our unit, we initiated studies to investigate the
molecular defects in beta-thalassaemias in Saudi Arabia using amplifi
cation-refractory mutation systems, dot blot analysis and restriction
endonuclease analysis, and identified mutations producing beta(+)- and
beta(o)-thalassaemias. Twenty of the mutations encountered in the Asi
an, Mediterranean, Chinese and other Arab populations were investigate
d. The most commonly encountered mutations in Saudi beta-thalassaemia
patients were IVS-I-110, IVS-II-1, CD 39, IVS-I-5 and IVS-I 3' end (-2
5), while frameshifts at CD 8/9, Cap+1 (A --> C) and CD 6 mutations we
re identified at a low frequency. These mutations account for 84.94% o
f the total beta-thalassaemia mutations. The remaining 15% remain unkn
own. This is the first report on the type and nature of mutations in S
audi beta-thalassaemia patients. It presents frequencies of twenty mut
ations and emphasises the need for further detailed investigations to
clarify the whole spectrum of beta-thalassaemia mutations in the Saudi
population.